Citations

Clear

1053 citation(s) found for "Andre, F".

Operative Condition–Dependent Response of Cardiac ATP-Sensitive K+Channels Toward Sulfonylureas
Brady, Peter A. , Alekseev, Alexey E., Terzic, André

Mayo Clinic

Circulation Research | June 12, 2012 | Volume: 82 | Issue: 2 | Pages: 272-278

10.1161/01.res.82.2.272 | PMID 9468198 Get It

Abstract—A defining property of ATP-sensitive K+(KATP) channels is inhibition by sulfonylurea drugs, yet the response of cardiac KATPchannels toward sulfonylureas during myocardial ischemia is not consistent. Altered channel sensitivity toward sulfonylureas has, in part, been ascribed to antagonism by cytosolic nucleotide diphosphates, although the mechanism of interaction remains unclear. Herein, in inside-out patches excised from cardiomyocytes, we observed a dual response of KATPchannels toward the sulfonylurea drug, glyburide, in the presence of cytosolic UDP. Specifically, glyburide failed to inhibit spontaneous KATPchannel activity in the presence of UDP but inhibited UDP-induced channel activity after rundown of spontaneous channel openings. Such behavior of KATPchannels cannot be explained by differences in the level of channel activity or by UDP-induced displacement of glyburide. Rather, the dual response toward the sulfonylurea could be attributed to a property of KATPchannels to switch between operative conditions (spontaneous versus UDP-induced) each associated with a distinct responsiveness toward ligands. Conversion of post-rundown KATPchannels to the spontaneously operative channel condition, by Mg-ATP, restored the ability of UDP to antagonize the inhibitory action of glyburide lost after rundown, suggesting that the response of the channel to glyburide is phosphorylation dependent. The existence of distinct operative conditions of cardiac KATPchannels could be the basis for the inconsistent response of the channel toward sulfonylurea drugs and should be considered when sulfonylureas are used to implicate the opening of KATPchannels in the myocardium.
Mechanical Unloading Versus Neurohumoral Stimulation on Myocardial Structure and Endocrine Function In Vivo
Lisý, Ondřej, Redfield, Margaret M. , Jovanovic, Sofija, Jougasaki, Michihisa , Jovanović, Aleksandar , Leskinen, Hanna, Burnett, John C. , Jovanovic, Sofija, Terzic, André

Mayo Clinic

Circulation | June 12, 2012 | Volume: 102 | Issue: 3 | Pages: 338-343

10.1161/01.cir.102.3.338 | PMID 10899099 Get It

Background —Mechanical load and humoral stimuli such as endothelin (ET) and angiotensin II (Ang II) are potent modulators of cardiac structure and endocrine function, specifically gene expression and production and release of atrial natriuretic peptide (ANP). We define the contribution of mechanical load compared with neurohumoral stimulation in vivo with specific focus on myocardial and circulating ANP during chronic myocardial unloading produced by thoracic inferior vena caval constriction (TIVCC). Methods and Results —TIVCC was produced by banding the IVC for 10 days in 7 dogs, whereas in the 6 control dogs, the band was not constricted. TIVCC was characterized by a decrease in cardiac output, right atrial pressure, and left ventricular (LV) end-diastolic diameter and marked activation of ET and Ang II in plasma and atrial and ventricular myocardium. Despite neurohumoral stimulation, LV mass index and myocyte diameters in unloaded hearts decreased, reflecting myocyte atrophy. The total number of myocytes in the LV remained unchanged. Atrial stores of ANP increased, but plasma ANP did not change, in association with a trend toward ANP gene expression to decrease in unloaded hearts. Conclusions —Chronic mechanical unloading of the heart results in myocardial atrophy and lack of activation of ANP synthesis despite marked neurohumoral stimulation by the growth promoters ET and Ang II.
Recombinant Cardiac ATP-Sensitive K+Channel Subunits Confer Resistance To Chemical Hypoxia-Reoxygenation Injury
Jovanović, Aleksandar , Jovanović, Sofija, Jovanović, Sofija, Lorenz, Eva , Terzic, André

Mayo Clinic

Circulation | June 12, 2012 | Volume: 98 | Issue: 15 | Pages: 1548-1555

10.1161/01.cir.98.15.1548 | PMID 9769309 Get It

Background—Opening of cardiac ATP-sensitive K+(KATP) channels has emerged as a promising but still controversial cardioprotective mechanism. Defining KATPchannel function at the level of recombinant channel proteins is a necessary step toward further evaluation of the cardioprotective significance of this ion conductance.Methods and Results—KATPchannel–deficient COS-7 cells were found to be vulnerable to chemical hypoxia-reoxygenation injury that induced significant cytosolic Ca2+loading (from 97±3 to 236±11 nmol/L). In these cells, the potassium channel opener pinacidil (10 μmol/L) did not prevent Ca2+loading (from 96±3 nmol/L before to 233±12 nmol/L after reoxygenation) or evoked membrane current. Cotransfection withKir6.2/SUR2Agenes, which encode cardiac KATPchannel subunits, resulted in a cellular phenotype that, in the presence of pinacidil (10 μmol/L), expressed K+current and gained resistance to hypoxia-reoxygenation (Ca2+concentration from 99±7 to 127±11 nmol/L;P>0.05). Both properties were abolished by the KATPchannel blocker glyburide (1 μmol/L). In COS-7 cells transfected with individual channel subunitsKir6.2orSUR2A, which alone do not form functional cardiac KATPchannels, pinacidil did not protect against hypoxia-reoxygenation.Conclusions—The fact that transfer of cardiac KATPchannel subunits protected natively KATPchannel–deficient cells provides direct evidence that the cardiac KATPchannel protein complex harbors intrinsic cytoprotective properties. These findings validate the concept that targeting cardiac KATPchannels should be considered a valuable approach to protect the myocardium against injury.
Atrial Septal Aneurysm in Adult Patients
Daniel, Werner G., Angermann, Christiane, Spes, Christoph, Khandheria, Bijoy K. , Kronzon, Itzhak, Freedberg, Robin S., Keren, Andre , Dennig, K, Engberding, Rolf, Sutherland, George R., Vered, Zvi, Erbel, Raimund, Visser, Cees A., Lindert, Oliver, Hausmann, Dirk, Wenzlaff, P, Mügge, Andreas , Spes, C

Mayo Clinic

Circulation | June 12, 2012 | Volume: 91 | Issue: 11 | Pages: 2785-2792

10.1161/01.cir.91.11.2785 | PMID 7758185 Get It

Background An atrial septal aneurysm (ASA) is a well-recognized abnormality of uncertain clinical relevance. We reevaluated the clinical significance of ASA in a large series of patients. The aims of the study were to define morphological characteristics of ASA by transesophageal echocardiography (TEE), to define the incidence of ASA-associated abnormalities, and to investigate whether certain morphological characteristics of ASA are different in patients with and without previous events compatible with cardiogenic embolism. Methods and Results Patients with ASA were enrolled from 11 centers between May 1989 and October 1993. All patients had to undergo transthoracic and transesophageal echocardiography within 24 hours of each other; ASA was defined as a protrusion of the aneurysm >10 mm beyond the plane of the atrial septum as measured by TEE. Patients with mitral stenosis or prosthesis or after cardiothoracic surgery involving the atrial septum were excluded. Based on these criteria, 195 patients 54.6±16.0 years old (mean±SD) were included in this study. Whereas TEE could visualize the region of the atrial septum and therefore diagnose ASA in all patients, ASA defined by TEE was missed by transthoracic echocardiography in 92 patients (47%). As judged from TEE, ASA involved the entire septum in 100 patients (51%) and was limited to the fossa ovalis in 95 (49%). ASA was an isolated structural defect in 62 patients (32%). In 106 patients (54%), ASA was associated with interatrial shunting (atrial septal defect, n=38; patent foramen ovale, n=65; sinus venosus defect, n=3). In only 2 patients (1%), thrombi attached to the region of the ASA were noted. Prior clinical events compatible with cardiogenic embolism were associated with 87 patients (44%) with ASA; in 21 patients (24%) with prior presumed cardiogenic embolism, no other potential cardiac sources of embolism were present. Length of ASA, extent of bulging, and incidence of spontaneous oscillations were similar in patients with and without previous cardiogenic embolism; however, associated abnormalities such as atrial shunts were significantly more frequent in patients with possible embolism. Conclusions As shown previously, TEE is superior to the transthoracic approach in the diagnosis of ASA. The most common abnormalities associated with ASA are interatrial shunts, in particular patent foramen ovale. In this retrospective study, patients with ASA (especially with shunts) showed a high frequency of previous clinical events compatible with cardiogenic embolism; in a significant subgroup of patients, ASA appears to be the only source of embolism, as judged by TEE. Our data are consistent with the view that ASA is a risk factor for cardiogenic embolism, but thrombi attached to ASA as detected by TEE are apparently rare.
Costophrenic Septal Lines in Pulmonary Venous Hypertension
Bruwer, André, Ellis, F. Henry, Kirklin, John W.

Mayo Clinic

Circulation | June 11, 2012 | Volume: 12 | Issue: 5 | Pages: 807-812

10.1161/01.cir.12.5.807 | PMID 13270337 Get It

On the thoracic roentgenograms of patients with mitral stenosis, costophrenic septal lines are frequently seen. These lines are a sign of pulmonary venous hypertension. They were not seen in a representative group of patients with pulmonary arterial hypertension but without pulmonary venous hypertension.
Gelastic seizures and hypothalamic hamartomas
Cascino, G. D., Andermann, Frédérick, Berkovic, Samuel F. , Sharbrough, F. W., Keene, D. L., Bladin, P. F., Feindel, William, Kuzniecky, Ruben , Kelly, Paul J , Olivier, André

Mayo Clinic

Neurology | May 13, 2012 | Volume: 43 | Issue: 4 | Pages: 747-747

10.1212/wnl.43.4.747 | PMID 8469334 Get It

Ranolazine Decreases Mechanosensitivity of the Voltage-Gated Sodium Ion Channel Na V 1.5
Strege, Peter R. , Reyes, Santiago , Bernard, Cheryl E., Makielski, Jonathan C., Ackerman, Michael J. , Farrugia, Gianrico , Beyder, Arthur , Terzic, André , Strege, Peter R

Mayo Clinic

Circulation | May 8, 2012 | Volume: 125 | Issue: 22 | Pages: 2698-2706

10.1161/circulationaha.112.094714 | PMID 22565935 Get It

Background— Na V 1.5 is a mechanosensitive voltage-gated sodium-selective ion channel responsible for the depolarizing current and maintenance of the action potential plateau in the heart. Ranolazine is a Na V 1.5 antagonist with antianginal and antiarrhythmic properties. Methods and Results— Mechanosensitivity of Na V 1.5 was tested in voltage-clamped whole cells and cell-attached patches by bath flow and patch pressure, respectively. In whole cells, bath flow increased peak inward current in both murine ventricular cardiac myocytes (24±8%) and human embryonic kidney 293 cells heterologously expressing Na V 1.5 (18±3%). The flow-induced increases in peak current were blocked by ranolazine. In cell-attached patches from cardiac myocytes and Na V 1.5-expressing human embryonic kidney 293 cells, negative pressure increased Na V peak currents by 27±18% and 18±4% and hyperpolarized voltage dependence of activation by −11 mV and −10 mV, respectively. In human embryonic kidney 293 cells, negative pressure also increased the window current (250%) and increased late open channel events (250%). Ranolazine decreased pressure-induced shift in the voltage dependence (IC 50 54 μmol/L) and eliminated the pressure-induced increases in window current and late current event numbers. Block of Na V 1.5 mechanosensitivity by ranolazine was not due to the known binding site on DIVS6 (F1760). The effect of ranolazine on mechanosensitivity of Na V 1.5 was approximated by lidocaine. However, ionized ranolazine and charged lidocaine analog (QX-314) failed to block mechanosensitivity. Conclusions— Ranolazine effectively inhibits mechanosensitivity of Na V 1.5. The block of Na V 1.5 mechanosensitivity by ranolazine does not utilize the established binding site and may require bilayer partitioning. Ranolazine block of Na V 1.5 mechanosensitivity may be relevant in disorders of mechanoelectric dysfunction.
Influence of Mitral Regurgitation Repair on Survival in the Surgical Treatment for Ischemic Heart Failure Trial
Grayburn, Paul , Sun, Benjamin , Rao, Vivek , She, Lilin , Jain, Anil, Chua, Yeow Leng , Daly, Richard C. , Senni, Michele , Mokrzycki, Krzysztof , Menicanti, Lorenzo , Oh, Jae K. , Michler, Robert E. , Wróbel, Krzysztof , Lee, Kerry L. , Deja, Marek Andrzej , Krejca, Michał , Lamy, Andre L. , Velazquez, Eric J. , Jones, Robert H. , Senni, Michele

Mayo Clinic

Circulation | May 2, 2012 | Volume: 125 | Issue: 21 | Pages: 2639-2648

10.1161/circulationaha.111.072256 | PMID 22553307 Get It

Background— Whether mitral valve repair during coronary artery bypass grafting (CABG) improves survival in patients with ischemic mitral regurgitation (MR) remains unknown. Methods and Results— Patients with ejection fraction ≤35% and coronary artery disease amenable to CABG were randomized at 99 sites worldwide to medical therapy with or without CABG. The decision to treat the mitral valve during CABG was left to the surgeon. The primary end point was mortality. Of 1212 randomized patients, 435 (36%) had none/trace MR, 554 (46%) had mild MR, 181 (15%) had moderate MR, and 39 (3%) had severe MR. In the medical arm, 70 deaths (32%) occurred in patients with none/trace MR, 114 (44%) in those with mild MR, and 58 (50%) in those with moderate to severe MR. In patients with moderate to severe MR, there were 29 deaths (53%) among 55 patients randomized to CABG who did not receive mitral surgery (hazard ratio versus medical therapy, 1.20; 95% confidence interval, 0.77–1.87) and 21 deaths (43%) among 49 patients who received mitral surgery (hazard ratio versus medical therapy, 0.62; 95% confidence interval, 0.35–1.08). After adjustment for baseline prognostic variables, the hazard ratio for CABG with mitral surgery versus CABG alone was 0.41 (95% confidence interval, 0.22–0.77; P =0.006). Conclusion— Although these observational data suggest that adding mitral valve repair to CABG in patients with left ventricular dysfunction and moderate to severe MR may improve survival compared with CABG alone or medical therapy alone, a prospective randomized trial is necessary to confirm the validity of these observations. Clinical Trial Registration— URL: http://www.clinicaltrials.gov . Unique identifier: NCT00023595.
Atrioventricular Nodal Ablation in Atrial Fibrillation: A Meta-Analysis of Biventricular vs. Right Ventricular Pacing Mode
Upadhyay, Gaurav A. , Ellenbogen, Kenneth A. , Hayes, David L. , Chatterjee, Neal A. , Ng, G. André , Ellenbogen, Kenneth A

Mayo Clinic

European Journal of Heart Failure | March 22, 2012 | Volume: 14 | Issue: 6 | Pages: 661-667

10.1093/eurjhf/hfs036 | PMID 22436544 Get It

Abstract Aims For patients with refractory atrial fibrillation (AF) undergoing atrioventricular nodal ablation (AVNA), initial single-chamber right ventricular (RV)-only pacing is standard. Given the deleterious effects of chronic RV-only pacing, the impact of an initial biventricular (BiV) pacing strategy post-ablation is of interest. Methods and results We conducted a meta-analysis to determine the effect of BiV vs. RV-only pacing in patients undergoing AVNA for refractory atrial fibrillation. A search of multiple electronic databases identified 921 reports, which included four randomized controlled trials (n = 534). Mean New York Heart Association (NYHA) class was 2.3 and mean left ventricular ejection fraction (LVEF) was 44%. When compared with RV-only pacing, BiV pacing was not associated with reduced mortality [risk ratio 0.85, 95% confidence interval (CI) 0.40–1.82, P = 0.68]. In three studies comprised of patients with left ventricular systolic dysfunction (mean EF 41 ± 3%), BiV pacing demonstrated a non-significant reduction in cardiac mortality (risk ratio 0.59, 95% CI 0.25–1.39; P = 0.23). Compared with RV-only pacing, BiV pacing was associated with significant improvement in symptoms [Minnesota Living with Heart Failure Questionnaire (MLWHFQ) 2.72 points fewer, 95% CI 1.45–3.99] and increased LVEF (+2.6%, 95% CI 1.69–3.44), but no significant change in 6 min walk distance (6MWD) (5.02 ms more, 95% CI −1.56 to 11.59; P = 0.13). Conclusions In patients with refractory AF undergoing AVNA, BiV pacing was not associated with significantly improved survival when compared with RV-only pacing. A modest, but significant improvement in structural and functional response to BiV pacing was observed.